RenovoRx, Inc.
RNXT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001574094
No open-market purchases or sales by RenovoRx, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $9.00M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in RenovoRx, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- −3 vs. Q2 2024
- Shares held
- 1.89M
- +1.00M (+113.3%) vs. Q2 2024
- Total value
- $2.00M
- +$1.00M (+100.2%) vs. Q2 2024
- New holders
- 2
- 3 more added
- Sold out
- 5
- 3 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RNXT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 28 | $9.00M |
| Q1 2026 | 31 | $8.58M |
| Q4 2025 | 33 | $6.83M |
| Q3 2025 | 31 | $9.04M |
| Q2 2025 | 25 | $11.6M |
| Q1 2025 | 27 | $9.98M |
| Q4 2024 | 18 | $1.31M |
| Q3 2024 | 13 | $2.00M |
| Q2 2024 | 17 | $1.01M |
| Q1 2024 | 10 | $441.6K |
| Q4 2023 | 12 | $758.1K |
| Q3 2023 | 14 | $473.5K |
| Q2 2023 | 9 | $552.2K |
| Q1 2023 | 12 | $9.64M |
| Q4 2022 | 11 | $2.75M |
| Q3 2022 | 13 | $2.49M |
| Q2 2022 | 11 | $2.35M |
| Q1 2022 | 12 | $482.0K |
| Q4 2021 | 9 | $506.0K |
| Q3 2021 | 8 | $1.02M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding RenovoRx, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of Montreal | 975,000 | $1.03M | 0.00% | +975,000 | New |
| ADAR1 Capital Management, LLC | 315,192 | $334.1K | 0.06% | −40,048−11.3% | Reduced |
| Geode Capital Management, LLC | 232,937 | $246.9K | 0.00% | +89,018+61.9% | Added |
| Nixon Peabody Trust Co | 97,165 | $103.0K | 0.01% | 00.0% | Unchanged |
| Millennium Management LLC | 82,353 | $87.3K | 0.00% | −3,963−4.6% | Reduced |
| Vanguard Group Inc | 56,737 | $60.1K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 49,232 | $52.2K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 35,520 | $37.7K | 0.00% | +35,520 | New |
| State Street Corp | 26,152 | $27.7K | 0.00% | 00.0% | Unchanged |
| Affinity Capital Advisors, LLC | 13,279 | $14.1K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,070 | $4.31K | 0.00% | −3,319−44.9% | Reduced |
| UBS Group AG | 2,236 | $2.37K | 0.00% | +931+71.3% | Added |
| Bank of America Corp | 196 | $208 | 0.00% | +14+7.7% | Added |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −26,195−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −11,743−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Family Firm, Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −203−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |